Table 2.
Patients' clinical characteristics (N=26)
*Treatment (bevacizumab, liposomal doxorubicin or radiotherapy) associated with compromised wound healing, †Diabetes, hypertension or cardiovascular disease.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.